Transcriptomics-Guided Personalized Prescription of Targeted Therapeutics for Metastatic ALK-Positive Lung Cancer Case Following Recurrence on ALK Inhibitors
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.01026
Full Text
Open PDFAbstract
Available in full text
Date
October 15, 2019
Authors
Publisher
Frontiers Media SA